Sonic completes acquisition of GLP
Tuesday, 02 September, 2008
Sonic Healthcare [ASX: SHL] has completed the acquisition of the German GLP Medical Group.
The deal, first announced in June, sees Sonic taking control of a company which employs some 250 staff, and an expected EBITDA of around $3.5 million for the 2008/09 financial year.
Sonic and GLP have a history of collaboration due to the proximity of the GLP labs to the Sonic-operated Bioscientia Healthcare and the Schottdorf group laboratories, all of which are located in Hamburg.
'Longevity gene' could reverse damage from rapid aging disease
A gene found in supercentenarians, who live exceptionally long lives, could counteract the...
How a common gene mutation increases liver disease risk
Liver damage can be caused in people after exposure to high levels of acrolein, especially in...
Gene therapy slows Huntington's disease progression in trial
Patients receiving the treatment were found to experience 75% less progression of the disease...
